roxindole

Known as: roxindol 
 

Topic mentions per year

Topic mentions per year

1992-2004
02419922004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Because little comparative information is available concerning receptor profiles of antiparkinson drugs, affinities of 14 agents… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2002
2002
The accompanying multivariate analysis of the binding profiles of antiparkinson agents revealed contrasting patterns of… (More)
Is this relevant?
2002
2002
Although certain antiparkinson agents interact with serotonin (5-HT) receptors, little information is available concerning… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1999
1999
Roxindole, a DA D2 receptor agonist (2-16 mg/kg) produced dose-dependent increase in percentage antinociception. The effect which… (More)
  • table I
  • figure I
  • table 2
Is this relevant?
1996
1996
The putative, selective dopamine (DA) dopamine-2 autoreceptor agonist roxindole, which also exhibits serotonin-1A-agonistic and 5… (More)
Is this relevant?
1996
1996
Roxindole (EMD 49980, 5-hydroxy-3-[4-(4-phenyl-1,2,3,6-tetrahydropyridyl(1))-butyl(1)]-indole mesylate), a selective dopamine… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
Spontaneous eye blink rate was assessed in cynomolgus monkeys treated intramuscularly with the high-efficacy dopamine (DA… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?
1994
1994
Twenty schizophrenic inpatients with either predominantly positive or predominantly negative symptoms were treated with the… (More)
Is this relevant?
1993
1993
Roxindole is a potent autoreceptor-“selective” dopamine agonist originally developed for the treatment of schizophrenic syndromes… (More)
  • table 1
Is this relevant?
1992
1992
The neuroleptic effect and tolerability of roxindole (EMD 49,980), an agonist of the dopamine-D2 autoreceptor, was studied during… (More)
Is this relevant?